Stem Cell Authority, Ltd. (SCAL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jan 15, 2026, 4:00 PM EST
Stem Cell Authority Revenue
In the fiscal year ending August 31, 2009, Stem Cell Authority had annual revenue of $3.33M with 11,044.25% growth. Stem Cell Authority had revenue of $601.01K in the half year ending July 31, 2007.
Revenue
3.33M
Revenue Growth
+11,044.25%
P/S Ratio
54.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
182.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2009 | 3.33M | 3.30M | 11,044.25% |
| Aug 31, 2008 | 29.86K | -1.10M | -97.35% |
| Aug 31, 2007 | 1.13M | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |